Prevention of vertical transmission of HIV-1 in Mallorca, Spain. Impact of antiretroviral therapy from 1995 to 2000

Medicina Clinica

Volumn 118, Issue 10, 2002, Pages 365-370

  Leyes, María ^a   Ciria, Luis ^a   de Gopegui, Rosa Ruiz ^a   Sánchez, Emilia ^a   Villalonga, Concepción ^a   de la Peña, Andrés ^a   Riera, Melchor ^a   Salas, Ana ^a   Ribas, ángeles ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Antirretroviral therapy; Caesarean section; Highly active antiretroviral therapy (HAART); HIV; Intravenous drugs users; Vertical transmission; Zidovudine

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE; ANTIRETROVIRUS AGENT; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE;

ADULT; ARTICLE; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; SPAIN; TIME; CESAREAN SECTION; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; INFANT; INFECTION RISK; INTRAVENOUS DRUG ABUSE; RISK ASSESSMENT; VAGINAL DELIVERY; VERTICAL TRANSMISSION;

ADULT; ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SPAIN; TIME FACTORS; ZIDOVUDINE;

EID: 0037161061     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72389-0     Document Type: Article

References (34)

1. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
2. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
3. Factors predictive of maternal-fetal transmission of HIV-1
4. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1
5. Análisis geográfico de la epidemia de sida en España 1988-1993
6. Vigilancia epidemiológica
7. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus
8. Recomendaciones sobre el uso de zidovudina (ZDV) en la prevención de la transmisión vertical del VIH
9. Centers for Disease Control. Public Health Service Task Force Recommendations for the use of antiretroviral drugs in pregnant women for maternal health and for reducing perinatal HIV-1 transmission in the United States
10. British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998)
11. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
12. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial
13. Centers for Disease Control. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age
14. Virus de la inmunodeficiencia humana (infección)
15. Es posible la eliminación de la transmisión vertical del virus de la inmunodeficiencia humana?
16. Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antiretrovírico en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2000 (II)
17. Centers for Disease Control. Public Health Service Task Force Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce United States
18. Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects
19. Viral load and HIV-1 vertical transmission
20. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
21. Vertical transmission of HIV-1: Maternal immune status and obstetric factors
22. Analysis of the maternal components of the AIDS Clinical Trial Group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1
23. Transmisión vertical del virus de la inmunodeficiencia humana: Seis años de evolución (1987-1992)
24. Estimación de la prevalencia de infección por VIH-1 en la embarazada y efectividad de la zidovudina administrada durante la gestación en la prevención de la transmission vertical
25. Lack of long-term effects of in utero exposure to zidovudine among ininfected children born to HIV-infected women
26. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
27. Transmisión vertical del VIH-1. Hasta dónde se puede reducir?
28. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. A meta-analysis of 15 prospective cohort studies
29. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: The protective role of caesarean section
30. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with mother's anti-hepatitis C virus immunoblotting pattern
31. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and infants transmission study
32. Increased risk of maternal infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1
33. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women
34. Castilla y Grupo para el estudio anónimo no relacionado de la seropre-valencia del VIH en recién nacidos. Evolución de la seroprevalencia del virus de la inmunodeficiencia humana en madres de 1999